Berkeley Lovelace Jr.
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Latest from Berkeley Lovelace Jr.
Ozempic may be linked to condition that causes blindness, but more research is needed
People taking Ozempic and Wegovy may be at increased risk of developing a debilitating eye condition that can cause irreversible vision loss, a study published in JAMA Ophthalmology finds.
FDA approves Eli Lilly's Alzheimer's drug Kisunla
The FDA approved a new Alzheimer’s drug that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities.
Biden and Trump's back-and-forth on insulin fails to address the sky-high cost of health care
During Thursday night’s debate, President Joe Biden and former President Donald Trump spent a considerable amount of time trying to claim credit for lowering the high cost of insulin.
Fact-checking Biden and Trump's claims at the first debate
Trump made a series of misleading claims on topics ranging from Jan. 6 to terrorism to taxes at the first 2024 presidential debate, while Biden flubbed some facts.
House committee passes bill that would allow Medicare to cover weight loss drugs
For more than two decades, a law has prohibited Medicare from paying for weight loss drugs, cutting off access to millions of potential patients who could stand to benefit.
Health care just as important as economy. What experts want Biden and Trump to address.
When Biden and Trump debate Thursday, health policy experts say tackling the exorbitant cost of health care is as much a top issue for voters as the U.S. economy.
Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefits
At the ADA conference in Orlando, researchers will present data on 27 GLP-1 drugs in development, while others focus on a different hormone.
'Novo Nordisk is ripping off the American people,' Bernie Sanders says of Ozempic and Wegovy costs
Sen. Bernie Sanders says the first question he is going to ask Novo Nordisk's CEO at a committee hearing is why Ozempic and Wegovy costs more in the U.S.
FDA advises Covid vaccine makers to target KP.2 for fall shots
The FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the highly contagious JN.1 variant that spread widely in the U.S. this winter.
What to know about the first human case of H5N2 bird flu
Should we be worried about the first human case of the H5N2 strain of bird flu? H5N2, confirmed in a man in Mexico who died, is different from the bird flu virus affecting cows in the U.S.
FDA panel recommends updating the Covid vaccines for the fall to target JN.1 strain
Although Covid cases remain low in the U.S., vaccine experts are already looking toward the winter, with eyes on preventing a seasonal surge.
